Q: Regarding todays nr, is it safe to assume the observations from the clinical trial are in a positive light? I have a small position and am considering adding - since the casino is closed. London, Ontario-TheNewswire -June 1, 2021 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF)(FSE/XETRA:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce that lead principal investigator Dr. Piotr Witkowski and the Clinical Trial Investigator Team for its US Phase I/II Type 1 Diabetes clinical trial will present data and observations from the ongoing study in a presentation at the upcoming American Transplant Congress (ATC) Virtual Connect to be held June 4 - 9, 2021.
Q: bought into this stock today for a 6 mth hold or longer if growth continues... seems management has been able to execute, has momentum, but your opinion would be appreciated
Q: May I have your comments about TLA. I bought a little bit six months ago thinking it a good value and it has risen since then. But most days it does not move at all. I am wondering if I should sell and move on.
Q: NVNXF Would like your thoughts on this company,they are looking to develope and supply lithium batteries for car and houses,they have an partnership with Emera to develope energy storage systems for community micro grids.
They seem to be getting their ducks in a row for potential commercial long term possibilities....
Thanks
Q: this company been on the market just over a year, was just up graded to $5.75 only 187M market cap, what can you tell me about im considering a 2% position thanks
Q: Recently, SuRo Capital Corp declared a dividend of $2.50 per share held. Share holders are given options to receive the dividend distribution in stock (option #1) or cash (option #2).
Please kindly give advice which is a better option (#1 or #2) for a share holder to take. Thank you very much. Bill
Q: This stock showed up on my radar and appears to have some insider buying. I notice it pays a dividend and in your past comments debt has been a concern. I am wondering what your current opinion is on this stock.
Q: Just opening the management circular dated may 3rd. The board members are mostly fairly new. the proposed options smorgasbord looks very appetizing for insiders. Also the insiders stakes are not generally high. No wonder since they cash their options a,s,a,p,. For such a small company the executives compensations are rich. The release coincide with the start of the marked decline in stock price.
The performance over 10 years has been outstanding and the yield today is attractive, What do you think of the newer board? do you see better opportunities for growth?
Thank you.
Hope you are enjoying a great start to the long weekend.
My question is on DNTL. At only single digit market share and already more than double their next competitor, it seems to have a massive runway in front of them, not to mention potential other healthcare verticals.
What are your thoughts on this company?
Q: Hi folks...Sangoma trading like it is going to zero..now in "Oversold" territory on technicals at $3sh level...big volume on Tues by TD & Cormack...the Q results imo, were not bad, and irrelevant with acquisition of Star2Star. Any thoughts on company & integration of business going forward..& would you be adding to position at these levels...merci beaucoup, jb Piedmont QC
Q: Would you recommend a STC to CTS switch at this very moment? Investing in small tech stocks much depends on entry timing. Hindsight tells me I got in on STC while it's on the start of a downward slide. Would a switch to CTS be like hopping from one downward slide onto another at this very moment too? Thanks for your insight.
Q: HRX appears to be meeting and beating earnings expectations and the price appears to be on an upward trend. Can you comment on your thoughts of adding this to a portfolio and if not this stock an alternative in this or a "similiar" sector.